Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

Patient characteristics of olfactory neuroblastoma: experience from a tertiary cancer centre 2000-2016 covering Eastern Denmark

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. APMIS pandemic editorial

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  2. Pandemics: past, present, future: That is like choosing between cholera and plague

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Beta-hemolytic streptococci A, C and G are susceptible to cloxacillin

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  4. The discovery of bacterial biofilm in patients with muscle invasive bladder cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Impact of human papillomavirus in sinonasal cancer-a systematic review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Systemic Immune Profile in Patients With CRSwNP

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

The aim of this study was to report incidence and patient characteristics of olfactory neuroblastoma (ONB) at a tertiary cancer institution during a 16-year period. A retrospective review was conducted on patients with ONB treated at Rigshospitalet, Copenhagen from 2000 to 2016 covering Eastern Denmark. Patient demographics, symptoms, stage, pathology-reports, treatment, and outcome were extracted from the patient records and the Danish pathology register. The tumours were graded both histologically and clinically using Hyam's and Kadish classifications, respectively. We identified a total of 14 patients (ten males, four females, median age 57 years, range 17-81 years). Four patients were in Kadish stage A, one stage B, and seven stage C. According to Hyam's classification, two tumours were grade I, nine grade II, and three grade III. All patients were treated with surgery, eight in combination with radiotherapy, where one received proton therapy, and one a combination with chemotherapy. At a median follow-up time of 58 months, the 5-year overall survival was 90% (95% CI 61; 99). ONB is a rare disease; complete radical surgery alone or combined with radiotherapy offered good oncologic control and outcome. Long-term follow-up of ONB should be mandatory.

TidsskriftAPMIS - Journal of Pathology, Microbiology and Immunology
Udgave nummer8
Sider (fra-til)663-666
Antal sider4
StatusUdgivet - aug. 2018

ID: 56645607